A group of researchers recently published a paper in the MDPI journal pharmaceutics that demonstrated the effectiveness of using lipid-biopolymer nanobeads as indomethacin (INDO) carriers to reduce drug toxicity.
Background
INDO, an orally administered non-steroidal anti-inflammatory (NSAID) agent, is used extensively for inflammation, fever, and pain control. However, the oral administration of INDO often leads to severe side effects, specifically in the gastrointestinal system, such as abdominal ache, indigestion, and diarrhea owing to the first-pass metabolism. Thus, new approaches are being investigated to lessen the INDO systemic toxicity and improve its overall efficacy.
Figure 1. Long-term stability of NLC formulations, monitored in terms of size (A), PDI (B), Zeta potential (C) and pH (D) values for up to a year, at 25 °C (n = 3; p < 0.05). © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
Colloidal drug delivery systems (DDS) with improved therapeutic actions can reduce the side effects by releasing the loaded drugs in a sustained manner. For instance, nanostructured lipid carriers (NLC) can be used to load and deliver various anti-inflammatory compounds through several drug administration routes. However, NLC as a colloid cannot provide the mucoadhesion and gastro-resistance required for oral administration of INDO.
Lipid–polymer nanohybrid formulations that contain at least a single nanostructured material in their composition can potentially merge the benefits of every excipient/carrier within a single DDS. Biopolymers are widely utilized as DDS as they are biodegradable, biocompatible, and versatile in nature. For instance, chitosan, a cationic polysaccharide, possesses exceptional mucoadhesive properties, which can be suitable for INDO administration.
However, chitosan displays sensitivity to acid media such as the gastric microenvironment. This issue can be resolved using xanthan gum (XAN), an anionic exopolysaccharide, as the coating agent of the lipid-polymer nanohybrid formulations such as nanobeads.
The Study
In this study, researchers combined two distinct strategies of coating and hybridization to decrease the INDO systemic toxicity and extend its release profile by simulating an oral administration. Initially, lipid–biopolymer nanobeads were synthesized in which NLC blended with chitosan solution encapsulated the INDO, and the nanobeads were coated by XAN. Later, they investigated the efficacy of the synthesized nanobeads and the reduction in INDO toxicity due to them.
Figure 2. Digital photo (left) of hybrid nanobeads (XAN@CHT/NLC-INDO) and particle size distribution (right), estimated by ImageJ software, (n = 3). © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), chitosan, XAN, INDO, Pluronic® 68 (P68), poloxamer, myristyl myristate (MM), coconut oil (CO), and deionized (DI) water with 18 MΩ resistivity were used as the starting materials.
2%, w/v NLC/INDO and NLC as control formulation were synthesized by the ultrasonication emulsification method, where MM acted as a solid lipid, poloxamer as a surfactant, and CO as a liquid lipid. Under magnetic stirring, the lipid phase containing CO and MM was briefly heated without or with 2% INDO at 10oC above the solid lipid melting point.
The aqueous phase containing 2-5% P68 was also heated at a similar temperature and then added to the lipid phase under high-speed homogenization for 3 min at 10,000 rpm in an Ultra-Turrax blender. Eventually, the obtained microemulsion was tip-sonicated at 20 kHz and 500 W in 30 s (on/off) cycles for 20 min, and then cooled in an ice bath to 25oC.
The polydispersity index (PDI) and particle size of the synthesized NLC/INDO and NLC formulations were determined using the dynamic light scattering (DLS) method, while the Zetasizer Nano ZS90 equipment was employed to measure their zeta potential values by electrophoretic light scattering. Researchers also determined the long-term physicochemical stability and in vitro cell viability of the samples and the INDO encapsulation efficiency.
Chitosan was scattered in 50 mL of 0.1% acetic acid, and XAN was dissolved in 50 mL DI water under magnetic stirring. Subsequently, 2% hydroalcoholic INDO solution was mixed with the chitosan solution and stirred at room temperature for 2 h to obtain chitosan/INDO beads.
In the preparation of chitosan/NLC-INDO hybrid nanobeads, half of the acetic acid solution was replaced with NLC loaded with 2% INDO for chitosan solubilization. The final XAN-coated forms were synthesized by initially immersing the aliquots of chitosan/NLC-INDO nanobeads and chitosan/INDO beads into 0.5% w/v XAN aqueous solution, then filtering and cooling them to −20oC, and finally freeze-drying.
Researchers performed the water uptake test and the INDO release test in in vitro mode, and in vivo toxicity assays through the chicken embryo model on the samples.
Observations
Ten distinct NLC formulations without and with INDO were successfully synthesized that showed a pale white color and a homogenous aspect. The physicochemical properties of NLC formulations remained suitable for use even after one year of storage, which indicated their long-term stability, and their INDO encapsulation efficiency was 99%.
The hybrid nanobeads of XAN-coated chitosan and NLC/INDO displayed exceptional thermodynamic, structural, and in vitro swelling properties, which indicated excellent compatibility between the biomaterials, and an extended drug release profile up to 26 hours.
Figure 3. Indomethacin in vitro release from beads (CHT/INDO and XAN@CHT/INDO) and nanobeads (CHT/NLC-INDO and XAN@CHT/NLC-INDO), quantified by UV-vis (λ = 210 nm) at 37 °C, n = 5. © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
The synergism observed between the biopolymer and nanolipid excipients helped in preventing the burst release effect within the first two hours of experiments, which simulated a gastric medium, followed by an extended-release in the pH 6.8, simulating an intestinal medium.
The XAN coating on nanobeads acted as a gastro-resistant excipient that protected chitosan and NLC/INDO from an unexpected swelling and prevented drug release in the initial hours of experiments.
The safety of the nanobeads was confirmed in the in vivo toxicity assay in chicken embryos (CE) as the combined benefits of coating and hybridization procedures reduced the inherent toxicity of INDO in chicken embryos.
Taken together, the findings of this study demonstrated that the lipid–biopolymer nanobead can be effectively used for delivering INDO, and other anti-inflammatories, through oral administration.

News
Can our mitochondria help to beat long Covid?
At Cambridge University’s MRC Mitochondrial Biology Unit, Michal Minczuk is one of a growing number of scientists around the world aiming to find new ways of improving mitochondrial health. This line of research could help [...]
Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break [...]
Graphene Nanosensor Detects Biomarkers Through Tears
In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor. The ability to detect [...]
How Nanotechnology Can Make a Splash in Aquaculture
Selenium (Se) is an essential element found in aquatic feeds that promotes the proper development, wellbeing, and fitness of marine animals. Selenium can be transformed into nanomaterials that are more easily accessible, absorbed, and consumed by [...]
Super-Resolution Imaging Method For Multiple Fluorescence Microscopy Applications
In an article recently published in the journal Nanotechnology, researchers employed a single particle imaging method for fluorescence excitation with moderate intensity to achieve spatial resolution. Here, the semiconductor nanocrystals were accessed, whose emission lifetimes [...]
Trials to begin on new SA COVID-19 vaccine
A new COVID-19 vaccine developed in South Australia and administered with a needle-free device is to begin human trials. Designed by University of Adelaide researchers the DNA vaccine also targets the Omicron variant of [...]
Towards Carbon Clean Manufacturing with Eco-Friendly Nano-Lubricants
Grinding is an essential manufacturing process, yet the heat due to friction associated with the process causes damage to the part being processed. Lubrication is used to reduce friction; however, traditional petroleum-based lubricants can [...]
Researchers develop hybrid sensor that could help diagnose cancer
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today, the device can identify gases and [...]
Scientists Develop ‘Nanomachines’ That Can Penetrate And Kill Cancer Cells
Researchers have made a scientific breakthrough with the development of ‘nanomachines’ that can kill cancerous cells. The research team headed by Dr Youngdo Jeong from the Center for Advanced Biomolecular Recognition at the Korea Institute of Science and Technology (KIST) has engineered [...]
Green Method to Make Nanoparticles and Ultrafine Powder
A novel freeze-dissolving approach has been devised that offers greater efficiency and sustainability compared to the classic freeze-drying process to make superfine powder or nanoparticles. In the research published in the journal ACS Sustainable Chemistry & Engineering, sphere-shaped [...]
Participants wanted for study on the regulation of what future AI-driven nanomedicines should look like
Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical [...]
Could gold nanoparticles help treat cancer?
Gold nanoparticles are minuscule particles made of gold. From drug and gene delivery to photothermal and photodynamic therapies to screening and diagnostic tests to radiation therapy, X-ray imaging and CT scans, these small particles [...]
Carbon Dots Target Nucleolus and Monitor in Real-Time
In an article recently published in the journal Applied Surface Science, the researchers synthesized green fluorescent carbon dots (G-CDs) from 3,5-diaminobenzoic acid and citric acid. The as-prepared G-CDs were used to target the nucleolus and [...]
Green Nanoformulation for Anti-Cancer and Antibacterial Functions
Doxorubicin (DOX) is a powerful anti-cancer medication, and efforts have been made to design nanostructures for delivering it to cancerous cells. The nanostructures increase the cytotoxic effects of DOX on cancerous cells, while reducing the negative effects [...]
New drug delivery system releases therapeutic cargo only when bacteria are present
A team of Brown University researchers has developed a new responsive material that is able to release encapsulated cargo only when pathogenic bacteria are present. The material could be used to make wound dressings [...]
Hairy Cell Leukemia Complicated by Severe COVID-19: A Case Study
Novel three-drug regimen used to manage life-threatening developments. In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone [...]